Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHKA known ✓ | P35790 | 1/20 | 0.39 |
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 known ✓ | P08173 | 1/20 | 0.38 |
| ▸ | CHRM5 known ✓ | P08912 | 1/20 | 0.38 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.38 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.38 |
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL19741470 | 0.94 | KMT2A (0.46) | KMT2AMEN1CYP2D6CYP2C9TP53 | |
| SCHEMBL5288762 | 0.84 | TP53 (0.48) | KMT2AMEN1CYP2D6CYP2C9TP53 | |
| SCHEMBL4895577 | 0.84 | MEN1 (0.54) | KMT2AMEN1CYP2D6CYP2C9TP53 | |
| Dimethylamine SCHEMBL19946001 | 0.83 | KMT2A (0.47) | KMT2AMEN1CYP2D6CYP2C9TP53 | |
| SCHEMBL13527279 | 0.82 | KMT2A (0.63) | KMT2AMEN1CYP2D6CYP2C9TP53 | |
| SCHEMBL5299708 | 0.82 | KMT2A (0.63) | KMT2AMEN1CYP2D6CYP2C9TP53 | |
| Hydrochloric Acid SCHEMBL30949615 | 0.82 | MAPT (0.52) | KMT2AMEN1CYP2D6CYP2C9TP53 | |
| Fluoride Ion SCHEMBL30212669 | 0.82 | CYP2D6 (0.47) | KMT2AMEN1CYP2D6CYP2C9TP53 | |
| Bromide SCHEMBL18604221 | 0.81 | MAOA (0.41) | CHRNA7CHRNA10CHRNA9CHKAHTR2A | |
| SCHEMBL5290223 | 0.80 | KMT2A (0.67) | KMT2AMEN1CYP2D6CYP2C9TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10308574-B2 | Reduction catalyst and chemical reactor | KABUSHIKI KAISHA TOSHIBA (JP) | 2019-06-04 | — | — | US | disclosed |
| US-20170369405-A1 | REDUCTION CATALYST AND CHEMICAL REACTOR | KABUSHIKI KAISHA TOSHIBA (JP) | 2017-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10308574-B2 | Reduction catalyst and chemical reactor | MPO, NOX4, IDH2 | CHKA 3577/4885CHRM2 1110/4885CHRM4 1208/4885 |
| US-20170369405-A1 | REDUCTION CATALYST AND CHEMICAL REACTOR | MPO, NOX4, IDH2 | CHKA 3577/4885CHRM2 1110/4885CHRM4 1208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.